Nymox Pharmaceutical Corp (NYMX) Posts Q3 Loss of 4c/Share
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/7/2026
- Wall St futures slip as yields and oil rebound; Fed minutes in focus
- Oil prices fall nearly 2% as Middle East supply concerns ease
- U.S. 10-year yield climb revives dotcom-era parallels: UBS weighs in
- Goldman flags 2 key market risks if a climb in yields persists
- Shell CEO says Middle East oil flows reach 80% of prewar levels
Tweet
Share
E-mailGet Alerts NYMX Hot Sheet
Join SI Premium – FREE
Nymox Pharmaceutical Corp (NASDAQ: NYMX) reported Q3 EPS of ($0.04), $0.02 better than the analyst estimate of ($0.06). Revenue for the quarter came in at $320 thousand versus the consensus estimate of $750 thousand.
For earnings history and earnings-related data on Nymox Pharmaceutical Corp (NYMX) click here.
For earnings history and earnings-related data on Nymox Pharmaceutical Corp (NYMX) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Citi raises TSMC price target to NT$4,000, keeps Buy rating
- FOMC minutes ahead; Constellation Brands reports - what’s moving markets
- Rosenblatt Reiterates Buy Rating on Marvell (MRVL)
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
